BROWSE·page 1550 of 1576

Browse EX-10 agreements

18,910 total material contract exhibits.


EX-10.4

EX-10.4

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

brainstorm cell therapeutics inc.

Warrant Shares: Issue Date: , 2026

​

…

EX-10.4·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.3

EX-10.3

​

Exhibit 10.3

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of May ___, 2026 between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

…

EX-10.3·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.2

EX-10.2

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.

THE ISSUE PRICE OF THIS NOTE IS $151,800.00

THE ORIGINAL ISSUE DISCOUNT IS $19,800.00

​

​ ​
Principal Amount: $151,800.00****Purchase Price: $132,000.00 Issue Date: May 11, 2026

​

PROMISSORY NOTE

…

EX-10.2·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.1

EX-10.1

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 11, 2026, by and between BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation, with its address at 1325 Avenue of Americas, 28th Floor, New York, New York 10019 (the “Company”), and Vanquish Funding Group Inc., a Virginia corporation, with its address at 1800 Diagonal Road, Suite 623, Alexandria VA 22314 (the “Buyer”).

WHEREAS:

A.The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”); and

…

EX-10.1·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.2

EX-10.2

PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED BECAUSE THEY ARE BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED BY THE MARK “[***]”

Execution Version













Amendment Deed



Corporate Markets Loan & Bank Guarantee Facility Agreement







National Australia Bank Limited



Reading Entertainment Australia Pty Ltd



Each Guarantor























































Corrs.com.au




Corrs Chambers Westgarth



Contents

…

EX-10.2·10-Q·CIK 716634·ACC 0000716634-26-000019·Filed May 17, 2026, 15:11 EDT

EX-10.1

EX-10.1

EXECUTION VERSION



TWELFTH AMENDMENT TO

SECOND AMENDED AND RESTATED CREDIT AGREEMENT



THIS TWELFTH AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT

AGREEMENT (this “Twelfth Amendment”), dated to be effective as of February 27, 2026, is entered into by and among Consolidated Amusement Holdings, LLC, a Nevada limited liability company (the “Borrower”), the Affiliates of the Borrower identified on the signature pages hereto (collectively, the “Guarantors”), the financial institutions identified on the signature pages hereto (collectively, the “Lenders”), and Bank of America, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, with reference to the following facts:

RECITALS

…

EX-10.1·10-Q·CIK 716634·ACC 0000716634-26-000019·Filed May 17, 2026, 15:11 EDT

EX-10.6

EX-10.6

SECOND AMENDED AND RESTATED

LIMITED LIABILITY COMPANY AGREEMENT

among

CONTEXTLOGIC HOLDINGS, LLC

and

THE MEMBERS NAMED HEREIN


Table of Contents

ARTICLE I DEFINITIONS 1
Section 1.01 Definitions 1
Section 1.02 Interpretation 11
ARTICLE II ORGANIZATION 12
Section 2.01 Formation 12
Section 2.02 Name 12
Section 2.03 Principal Office 12
Section 2.04 Registered Office; Registered Agent 12
Section 2.05 Purpose; Powers 12
Section 2.06 Term 12
Section 2.07 No State-Law Partnership; Tax Treatment 13
ARTICLE III UNITS 13
Section 3.01 Units Generally 13
Section 3.02 Authorization of Units 13
Section 3.03 Class A Convertible Preferred Units; Class B Common Units; Class P Units 13
Section 3.04 Conversion of Class A Convertible Preferred Units 14
Section 3.05 Other Issuances 14
Section 3.06 Preemptive Rights 15

…

EX-10.6·10-Q·CIK 2064307·ACC 0002064307-26-000004·Filed May 17, 2026, 15:11 EDT

EX-10.1

EX-10.1

Exhibit 10.1 CLASS A-1 NOTE PURCHASE AGREEMENT (SECURED FUND FEE REVENUE VARIABLE FUNDING NOTES, SERIES 2026-1, CLASS A-1) dated as of May 11, 2026 among DIGITALBRIDGE ISSUER, LLC, as the Issuer, DIGITALBRIDGE CO-ISSUER, LLC, as the Co-Issuer, DIGITALBRIDGE HOLDINGS 1, LLC, DIGITALBRIDGE HOLDINGS 2, LLC and DIGITALBRIDGE HOLDINGS 3, LLC, as the Asset Entities, DIGITALBRIDGE INVESTMENT HOLDCO, LLC, as the Manager, CERTAIN CONDUIT INVESTORS, each as a Conduit Investor, CERTAIN FINANCIAL INSTITUTIONS, each as a Committed Note Purchaser, CERTAIN FUNDING AGENTS, and BARCLAYS BANK PLC, as Letter of Credit Provider and as the Series 2026-1 Class A-1 Administrative Agent


…

EX-10.1·8-K·CIK 1679688·ACC 0001679688-26-000059·Filed May 17, 2026, 15:11 EDT

EX-10.1

EX-10.1

Execution Version

EXHIBIT 10.1

SECOND AMENDMENT TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENT

This SECOND AMENDMENT TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of May 15, 2026 (this “Amendment”) is made by and among NOVANTA CORPORATION, a Michigan corporation (the “Lead Borrower”), NOVANTA UK INVESTMENTS HOLDING LIMITED, a private limited company incorporated in England and Wales (the “U.K. Borrower”), Novanta Europe GmbH, a limited liability company (Gesellschaft mit beschränkter Haftung) formed and existing under the laws of Germany (the “German Borrower”), NOVANTA INC., a company continued and existing under the laws of the Province of New Brunswick, Canada (“Holdings” and, jointly and severally with the Lead Borrower, the U.K. Borrower and the German Borrower, collectively, the “Borrowers”, and each individually a “Borrower”), each of the Subsidiaries of Holdings listed under the caption “GUARANTORS” on the signature pages hereto (each a “Guarantor” and collectively the “Guarantors”), each lender party hereto as a 2026 Delayed Draw Term Loan Lender (as defined b

…

EX-10.1·8-K·CIK 1076930·ACC 0001193125-26-227053·Filed May 17, 2026, 15:02 EDT

EX-10.3

EX-10.3

FORBEARANCE AGREEMENT AND WAIVER TO CREDIT AGREEMENT

This FORBEARANCE AGREEMENT AND WAIVER TO CREDIT AGREEMENT, dated as of May 11, 2026 (this “May 2026 Waiver”), is entered into by and among Boxlight Corporation, a Nevada corporation (the “Borrower”), each Subsidiary of the Borrower listed as a “Guarantor” on the signature pages hereto (each a “Guarantor” and collectively, the “Guarantors”), the financial institutions party hereto as Lenders and Whitehawk Capital Partners LP (“Whitehawk Capital”), as the Administrative Agent.

…

EX-10.3·10-Q·CIK 1624512·ACC 0001628280-26-035695·Filed May 17, 2026, 15:01 EDT

EX-10.4

EX-10.4

Exhibit 10.4

FIRST AMENDMENT TO BLACK TITAN CORPORATION

SENIOR UNSECURED CONVERTIBLE NOTE

This FIRST AMENDMENT TO THE BLACK TITAN CORPORATION SENIOR UNSECURED CONVERTIBLE NOTE (THIS “AMENDMENT”), as issued by Black Titan Corporation (the “Company”) is made and effective as of May 11, 2026 (“Effective Date”), by and among the Company, and the signatory hereto (the “Holder”).

RECITALS

WHEREAS, on January 16, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and between the Company and the Holder, pursuant to which the Holder purchased a Senior Unsecured Convertible Note (the “Note”) from the Company upon the terms and conditions set forth in the Purchase Agreement and the Note;

WHEREAS, Section 18 of the Note provides that, except for Section 3(d), which may not be amended, modified or waived by the parties to the Note, the prior written consent of the Required Holder (as defined in the Purchase Agreement) is required for any amendment, modification or waiver of the Note;

…

EX-10.4·6-K·CIK 2034400·ACC 0001493152-26-023895·Filed May 17, 2026, 15:01 EDT

EX-10.3

EX-10.3

Exhibit 10.3

FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT

This FIRST AMENDMENT TO THE REGISTRATION RIGHTS AGREEMENT (THIS “AMENDMENT”), is made and effective as of May 11, 2026, by and among Black Titan Corporation, a Cayman Islands exempted company (the “Company”), and the holder of registration rights under the Registration Rights Agreement (defined below) signatory hereto (the “Holder”).

RECITALS

WHEREAS, on January 16, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and between the Company and the Holder, pursuant to which the Holder purchased a Senior Unsecured Convertible Note (the “Note”) from the Company upon the terms and conditions set forth in the Purchase Agreement and the Note;

WHEREAS, on January 16, 2026, the Company agreed to provide certain registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement) to the Holder pursuant to that certain Registration Rights Agreement, dated as of January 16, 2026 (the “Registration Rights Agreement”);

…

EX-10.3·6-K·CIK 2034400·ACC 0001493152-26-023895·Filed May 17, 2026, 15:01 EDT